{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:46:41Z","timestamp":1772027201947,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Province Medical Science and Technology Tackling Program (Jointly Co-construction) Project","award":["LHGJ20190658"],"award-info":[{"award-number":["LHGJ20190658"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aims to explore novel and reliable biomarkers for predicting hepatocellular carcinoma (HCC) prognosis. Circular RNAs (circRNAs) were determined by analysis of human circRNA arrays and quantitative reverse transcription polymerase reactions. To test for an interaction between circDLG1, we used luciferase reporter assays, RNA immunoprecipitation, and fluorescence <jats:italic>in situ<\/jats:italic> hybridization assays that were employed to test the interaction between circDLG1, miR-141-3p, and WTAP. q-RT-PCR and western blot were used to evaluate the target regulation of miR-141-3p and WTAP. shRNA-mediated knockdown of circDLG1, proliferation, migration, and invasion experiment of metastasis were used to evaluate the function of circDLG. CircDLG1 rather than lining DLG1 was upregulated in HCC tissues, from HCC patients as well as HCC cell lines compared to normal controls. circDLG1 high expression in HCC patients was correlated with shorter overall survival. Knockdown of circDLG1 and miR-141-3p mimic could inhibit the tumorigenesis of HCC cells <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. Importantly, we demonstrated that circDLG1 could act as a sponge of miR-141-3p to regulate the expression of WTAP, and further suppress the tumorigenesis of HCC cells. Our study reveals that circDLG1 can serve as a novel potential circulating biomarker for the detection of HCC. circDLG1 participates in the progression of HCC cells by sponging miR-141-3p with WTAP, providing new insight into the treatment of HCC.<\/jats:p>","DOI":"10.1007\/s10142-023-01096-y","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T13:02:21Z","timestamp":1685019741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["RETRACTED ARTICLE: Circular RNA circDLG1 contributes to HCC progression by regulating the miR-141-3p\/WTAP axis"],"prefix":"10.1007","volume":"23","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0820-7392","authenticated-orcid":false,"given":"Changshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/14728220903307509","volume":"13","author":"T Amann","year":"2009","unstructured":"Amann T, Hellerbrand C (2009) GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 13:1411\u20131427. https:\/\/doi.org\/10.1517\/14728220903307509","journal-title":"Expert Opin Ther Targets"},{"key":"1096_CR2","doi-asserted-by":"publisher","unstructured":"Bai L, Yu Z, Li Q, Hu X, Liu X, Li F, Li S, Chen Y (2023) Circ_0073228 serves as a competitive endogenous RNA to facilitate proliferation and inhibit apoptosis of hepatocellular carcinoma cells by the miR-139\u20135p\/DNASE2 axis. J Gene Med:e3507. https:\/\/doi.org\/10.1002\/jgm.3507","DOI":"10.1002\/jgm.3507"},{"key":"1096_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1590\/0102-6720201700040011","volume":"30","author":"MF Chedid","year":"2017","unstructured":"Chedid MF, Kruel CRP, Pinto MA, Grezzana-Filho TJM, Leipnitz I, Kruel CDP, Scaffaro LA, Chedid AD (2017) Hepatocellular carcinoma: diagnosis and operative management. Arq Bras Cir Dig 30:272\u2013278. https:\/\/doi.org\/10.1590\/0102-6720201700040011","journal-title":"Arq Bras Cir Dig"},{"key":"1096_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen LL, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12:381\u2013388. https:\/\/doi.org\/10.1080\/15476286.2015.1020271","journal-title":"RNA Biol"},{"key":"1096_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, Chen D, Yang B, He B, Hu W, Zhang Y, Liu H, Dai L, Xie H, Zhou L, Wu J, Zheng S (2019) WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer 18:127. https:\/\/doi.org\/10.1186\/s12943-019-1053-8","journal-title":"Mol Cancer"},{"key":"1096_CR6","doi-asserted-by":"publisher","first-page":"9965","DOI":"10.2147\/cmar.s270164","volume":"12","author":"L Chen","year":"2020","unstructured":"Chen L, Chi K, Xiang H, Yang Y (2020) Circ_0032821 facilitates gastric cancer cell proliferation, migration, invasion and glycolysis by regulating MiR-1236-3p\/HMGB1 axis. Cancer Manag Res 12:9965\u20139976. https:\/\/doi.org\/10.2147\/cmar.s270164","journal-title":"Cancer Manag Res"},{"key":"1096_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"DL Chen","year":"2021","unstructured":"Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, Song K, Xu RH (2021) The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer 20:166. https:\/\/doi.org\/10.1186\/s12943-021-01475-8","journal-title":"Mol Cancer"},{"key":"1096_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, Au J, Long CP, Antoniewicz MR, Hay N (2018) Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun 9:446. https:\/\/doi.org\/10.1038\/s41467-017-02733-4","journal-title":"Nat Commun"},{"key":"1096_CR9","doi-asserted-by":"publisher","unstructured":"Ding N, You AB, Yang H, Hu GS, Lai CP, Liu W, Ye F (2023) A tumor suppressive-molecular axis EP300\/circRERE\/miR-6837-3p\/MAVS activates type I interferon pathway and anti-tumor immunity to suppress colorectal cancer. Clin Cancer Res 22\u20133836. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3836","DOI":"10.1158\/1078-0432.CCR-22-3836"},{"key":"1096_CR10","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1080\/15476286.2016.1269999","volume":"14","author":"R Dong","year":"2017","unstructured":"Dong R, Ma XK, Chen LL, Yang L (2017) Increased complexity of circRNA expression during species evolution. RNA Biol 14:1064\u20131074. https:\/\/doi.org\/10.1080\/15476286.2016.1269999","journal-title":"RNA Biol"},{"key":"1096_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245\u20131255. https:\/\/doi.org\/10.1016\/S0140-6736(11)61347-0","journal-title":"Lancet"},{"key":"1096_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301\u20131314. https:\/\/doi.org\/10.1016\/S0140-6736(18)30010-2","journal-title":"Lancet"},{"key":"1096_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10142-022-00933-w","volume":"23","author":"B Gao","year":"2022","unstructured":"Gao B, Wang Y, Lu S (2022) Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment. Funct Integr Genomics 23:6. https:\/\/doi.org\/10.1007\/s10142-022-00933-w","journal-title":"Funct Integr Genomics"},{"key":"1096_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han D, Li J, Wang H, Su X, Hou J, Gu Y, Qian C, Lin Y, Liu X, Huang M, Li N, Zhou W, Yu Y, Cao X (2017) Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology (baltimore, MD) 66:1151\u20131164. https:\/\/doi.org\/10.1002\/hep.29270","journal-title":"Hepatology (baltimore, MD)"},{"key":"1096_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.semdp.2016.12.011","volume":"34","author":"J Hartke","year":"2017","unstructured":"Hartke J, Johnson M, Ghabril M (2017) The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol 34:153\u2013159. https:\/\/doi.org\/10.1053\/j.semdp.2016.12.011","journal-title":"Semin Diagn Pathol"},{"key":"1096_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12041-021-01268-4","volume":"100","author":"A Hatibaruah","year":"2021","unstructured":"Hatibaruah A, Rahman M, Agarwala S, Singh SA, Shi J, Gupta S, Paul P (2021) Circular RNAs in cancer and diabetes. J Genet 100:21","journal-title":"J Genet"},{"key":"1096_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature20577","volume":"540","author":"IU Haussmann","year":"2016","unstructured":"Haussmann IU, Bodi Z, Sanchez-Moran E, Mongan NP, Archer N, Fray RG, Soller M (2016) m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540:301\u2013304. https:\/\/doi.org\/10.1038\/nature20577","journal-title":"Nature"},{"key":"1096_CR18","doi-asserted-by":"publisher","first-page":"17278","DOI":"10.1073\/pnas.0608357103","volume":"103","author":"K Horiuchi","year":"2006","unstructured":"Horiuchi K, Umetani M, Minami T, Okayama H, Takada S, Yamamoto M, Aburatani H, Reid PC, Housman DE, Hamakubo T, Kodama T (2006) Wilms\u2019 tumor 1-associating protein regulates G2\/M transition through stabilization of cyclin A2 mRNA. Proc Natl Acad Sci USA 103:17278\u201317283. https:\/\/doi.org\/10.1073\/pnas.0608357103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1096_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.20892\/j.issn.2095-3941.2022.0466","volume":"20","author":"F Hu","year":"2023","unstructured":"Hu F, Peng Y, Fan X, Zhang X, Jin Z (2023) Circular RNAs: implications of signaling pathways and bioinformatics in human cancer. Cancer Biol Med 20:104\u2013128. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0466","journal-title":"Cancer Biol Med"},{"key":"1096_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, Jiang J, Wang L, Mang Y, Gao Y, Zhang S, Ran J, Li L (2023) Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer 22:55. https:\/\/doi.org\/10.1186\/s12943-023-01759-1","journal-title":"Mol Cancer"},{"key":"1096_CR21","doi-asserted-by":"publisher","first-page":"33911","DOI":"10.18632\/oncotarget.15411","volume":"8","author":"JF Jiang","year":"2017","unstructured":"Jiang JF, Lao YC, Yuan BH, Yin J, Liu X, Chen L, Zhong JH (2017) Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges. Oncotarget 8:33911\u201333921. https:\/\/doi.org\/10.18632\/oncotarget.15411","journal-title":"Oncotarget"},{"key":"1096_CR22","doi-asserted-by":"publisher","first-page":"1007696","DOI":"10.3389\/fgene.2022.1007696","volume":"13","author":"J Lei","year":"2022","unstructured":"Lei J, Fan Y, Yan C, Jiamaliding Y, Tang Y, Zhou J, Huang M, Ju G, Wu J, Peng C (2022) Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. Front Genet 13:1007696. https:\/\/doi.org\/10.3389\/fgene.2022.1007696","journal-title":"Front Genet"},{"key":"1096_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, Zhu P, Chang Z, Wu Q, Zhao Y, Jia Y, Xu P, Liu H, Shan G (2015) Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 22:256\u2013264. https:\/\/doi.org\/10.1038\/nsmb.2959","journal-title":"Nat Struct Mol Biol"},{"key":"1096_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41418-021-00905-w","volume":"29","author":"ZX Li","year":"2022","unstructured":"Li ZX, Zheng ZQ, Yang PY, Lin L, Zhou GQ, Lv JW, Zhang LL, Chen F, Li YQ, Wu CF, Li F, Ma J, Liu N, Sun Y (2022) WTAP-mediated m(6)A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis. Cell Death Differ 29:1137\u20131151. https:\/\/doi.org\/10.1038\/s41418-021-00905-w","journal-title":"Cell Death Differ"},{"key":"1096_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/oxfordjournals.hmg.a018914","volume":"9","author":"NA Little","year":"2000","unstructured":"Little NA, Hastie ND, Davies RC (2000) Identification of WTAP, a novel Wilms\u2019 tumour 1-associating protein. Hum Mol Genet 9:2231\u20132239. https:\/\/doi.org\/10.1093\/oxfordjournals.hmg.a018914","journal-title":"Hum Mol Genet"},{"key":"1096_CR26","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.1038\/s41598-017-14813-y","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Wu H, Mei Y, Ding X, Yang X, Li C, Deng M, Gong J (2017) Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma. Sci Rep 7:15294. https:\/\/doi.org\/10.1038\/s41598-017-14813-y","journal-title":"Sci Rep"},{"key":"1096_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, H\u00e4ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390. https:\/\/doi.org\/10.1056\/NEJMoa0708857","journal-title":"N Engl J Med"},{"key":"1096_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12032-022-01830-9","volume":"39","author":"Q Luo","year":"2022","unstructured":"Luo Q, Zhan X, Kuang Y, Sun M, Dong F, Sun E, Chen B (2022) WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m(6)A-dependent manner. Med Oncol 39:231. https:\/\/doi.org\/10.1007\/s12032-022-01830-9","journal-title":"Med Oncol"},{"issue":"Suppl 1","key":"1096_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000481246","volume":"93","author":"N Nishida","year":"2017","unstructured":"Nishida N, Kudo M (2017) Oncogenic signal and tumor microenvironment in hepatocellular carcinoma. Oncology 93(Suppl 1):160\u2013164. https:\/\/doi.org\/10.1159\/000481246","journal-title":"Oncology"},{"key":"1096_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"1096_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/gutjnl-2020-321702","volume":"70","author":"M Pinter","year":"2021","unstructured":"Pinter M, Scheiner B, Peck-Radosavljevic M (2021) Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut 70:204\u2013214. https:\/\/doi.org\/10.1136\/gutjnl-2020-321702","journal-title":"Gut"},{"key":"1096_CR32","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.2147\/cmar.s272274","volume":"12","author":"C Qi","year":"2020","unstructured":"Qi C, Qin X, Zhou Z, Wang Y, Yang Q, Liao T (2020) Circ_0072995 promotes cell carcinogenesis via up-regulating miR-149-5p-mediated SHMT2 in breast cancer. Cancer Manag Res 12:11169\u201311181. https:\/\/doi.org\/10.2147\/cmar.s272274","journal-title":"Cancer Manag Res"},{"key":"1096_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1080\/15476286.2016.1220473","volume":"14","author":"S Qu","year":"2017","unstructured":"Qu S, Zhong Y, Shang R, Zhang X, Song W, Kjems J, Li H (2017) The emerging landscape of circular RNA in life processes. RNA Biol 14:992\u2013999. https:\/\/doi.org\/10.1080\/15476286.2016.1220473","journal-title":"RNA Biol"},{"key":"1096_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1093526619875228","volume":"23","author":"S Ranganathan","year":"2020","unstructured":"Ranganathan S, Lopez-Terrada D, Alaggio R (2020) Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol 23:79\u201395. https:\/\/doi.org\/10.1177\/1093526619875228","journal-title":"Pediatr Dev Pathol"},{"key":"1096_CR35","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.2147\/ott.s175826","volume":"11","author":"J Rong","year":"2018","unstructured":"Rong J, Wang Q, Zhang Y, Zhu D, Sun H, Tang W, Wang R, Shi W, Cao XF (2018) Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma. Onco Targets Ther 11:6723\u20136730. https:\/\/doi.org\/10.2147\/ott.s175826","journal-title":"Onco Targets Ther"},{"key":"1096_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME (2016) Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17:272\u2013283. https:\/\/doi.org\/10.1038\/nrg.2016.20","journal-title":"Nat Rev Genet"},{"key":"1096_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/14737159.2019.1638254","volume":"19","author":"S Umeda","year":"2019","unstructured":"Umeda S, Kanda M, Kodera Y (2019) Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Rev Mol Diagn 19:725\u2013738. https:\/\/doi.org\/10.1080\/14737159.2019.1638254","journal-title":"Expert Rev Mol Diagn"},{"key":"1096_CR38","doi-asserted-by":"publisher","first-page":"110661","DOI":"10.1016\/j.cellsig.2023.110661","volume":"107","author":"J Wang","year":"2023","unstructured":"Wang J, Zheng L, Hu C, Kong D, Zhou Z, Wu B, Wu S, Fei F, Shen Y (2023) CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Cell Signal 107:110661. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110661","journal-title":"Cell Signal"},{"key":"1096_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12935-019-0975-y","volume":"19","author":"J Wei","year":"2019","unstructured":"Wei J, Wang J, Gao X, Qi F (2019) Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer. Cancer Cell Int 19:268. https:\/\/doi.org\/10.1186\/s12935-019-0975-y","journal-title":"Cancer Cell Int"},{"key":"1096_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1126\/science.1238522","volume":"340","author":"JE Wilusz","year":"2013","unstructured":"Wilusz JE, Sharp PA (2013) Molecular biology. A circuitous route to noncoding RNA. Science (new York, NY) 340:440\u2013441. https:\/\/doi.org\/10.1126\/science.1238522","journal-title":"Science (new York, NY)"},{"key":"1096_CR41","doi-asserted-by":"publisher","first-page":"100503","DOI":"10.1016\/j.mtbio.2022.100503","volume":"17","author":"X Xu","year":"2022","unstructured":"Xu X, Cui J, Wang H, Ma L, Zhang X, Guo W, Xue X, Wang Y, Qiu S, Tian X, Miao Y, Wu M, Yu Y, Xu Y, Wang J, Qiao Y (2022) IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Mater Today Bio 17:100503. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100503","journal-title":"Mater Today Bio"},{"key":"1096_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10142-021-00803-x","volume":"21","author":"LR Yan","year":"2021","unstructured":"Yan LR, Ding HX, Shen SX, Lu XD, Yuan Y, Xu Q (2021) Pepsinogen C expression-related lncRNA\/circRNA\/mRNA profile and its co-mediated ceRNA network in gastric cancer. Funct Integr Genomics 21:605\u2013618. https:\/\/doi.org\/10.1007\/s10142-021-00803-x","journal-title":"Funct Integr Genomics"},{"key":"1096_CR43","doi-asserted-by":"publisher","first-page":"2192438","DOI":"10.1080\/15592294.2023.2192438","volume":"18","author":"H Zhai","year":"2023","unstructured":"Zhai H, Zhong S, Wu R, Mo Z, Zheng S, Xue J, Meng H, Liu M, Chen X, Zhang G, Zheng X, Du F, Li R, Zhou B (2023) Suppressing circIDE\/miR-19b-3p\/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma. Epigenetics 18:2192438. https:\/\/doi.org\/10.1080\/15592294.2023.2192438","journal-title":"Epigenetics"},{"key":"1096_CR44","doi-asserted-by":"publisher","first-page":"e23049","DOI":"10.1002\/jcla.23049","volume":"34","author":"H Zhang","year":"2020","unstructured":"Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao B, Sun W (2020) The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal 34:e23049. https:\/\/doi.org\/10.1002\/jcla.23049","journal-title":"J Clin Lab Anal"},{"key":"1096_CR45","doi-asserted-by":"publisher","first-page":"925","DOI":"10.21037\/jtd.2019.12.57","volume":"12","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Chen Y, Jiang H, Zhang H, Wang H, Xu J, Yu Z (2020) Circ_0058063 upregulates GLUT1 expression and promotes glucose-uptake in esophageal squamous-cell carcinomas. J Thorac Dis 12:925\u2013931. https:\/\/doi.org\/10.21037\/jtd.2019.12.57","journal-title":"J Thorac Dis"},{"key":"1096_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-023-02624-1","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Yan X, Lu T, Song W, Li Y, Liang J, Zhang J, Cai J, Sui X, Xiao J, Chen H, Chen G, Zhang Q, Liu Y, Yang Y, Zheng K, Pan Z (2023) CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect. J Exp Clin Cancer Res 42:63. https:\/\/doi.org\/10.1186\/s13046-023-02624-1","journal-title":"J Exp Clin Cancer Res"},{"key":"1096_CR47","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41598-023-30567-2","volume":"13","author":"G Zhong","year":"2023","unstructured":"Zhong G, Lin Y, Huang Z (2023) Identification of a novel circRNA-miRNA-mRNA regulatory axis in hepatocellular carcinoma based on bioinformatics analysis. Sci Rep 13:3728. https:\/\/doi.org\/10.1038\/s41598-023-30567-2","journal-title":"Sci Rep"},{"key":"1096_CR48","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.21037\/atm-22-5750","volume":"10","author":"R Zhu","year":"2022","unstructured":"Zhu R, Gao C, Feng Q, Guan H, Wu J, Samant H, Yang F, Wang X (2022) Ferroptosis-related genes with post-transcriptional regulation mechanisms in hepatocellular carcinoma determined by bioinformatics and experimental validation. Ann Transl Med 10:1390. https:\/\/doi.org\/10.21037\/atm-22-5750","journal-title":"Ann Transl Med"},{"key":"1096_CR49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hep.31280","volume":"73","author":"Q Zuo","year":"2021","unstructured":"Zuo Q, He J, Zhang S, Wang H, Jin G, Jin H, Cheng Z, Tao X, Yu C, Li B, Yang C, Wang S, Lv Y, Zhao F, Yao M, Cong W, Wang C, Qin W (2021) PPAR\u03b3 coactivator-1\u03b1 suppresses metastasis of hepatocellular carcinoma by inhibiting Warburg effect by PPAR\u03b3-dependent WNT\/\u03b2-catenin\/pyruvate dehydrogenase kinase isozyme 1 axis. Hepatology (baltimore, MD) 73:644\u2013660. https:\/\/doi.org\/10.1002\/hep.31280","journal-title":"Hepatology (baltimore, MD)"}],"updated-by":[{"DOI":"10.1007\/s10142-024-01375-2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"record-id":"53992"},{"DOI":"10.1007\/s10142-024-01375-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000}}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-01096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-023-01096-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-01096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T09:07:33Z","timestamp":1715332053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-023-01096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s10142-023-01096-y","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10142-024-01375-2","URL":"https:\/\/doi.org\/10.1007\/s10142-024-01375-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used the patient\u2019s tissues and was performed according to the declaration of Helsinki and was approved by the Affiliated Cancer Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"179"}}